Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S3.15
P/E—
Fwd P/E14.55
PEG0.93
52W— – —
RSI—
Target$210.29 (+16.8%)
Beta1.67
Div—
Loading chart…
RSI (14)
Loading patterns…
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 54
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
2Bullish
1Bearish
0Neutral
▲ Bull Flag — Breakout after +11% pole — bullish continuation
▲ Inv. Head & Shoulders — Inv. H&S neckline ~$182.19 broken — major bullish reversal
▼ Bear Flag — Breakdown after -14% pole — bearish continuation
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
75%
6/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$210.29
+16.8% upside
Low $175
—
High $240
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| BMO Capital | Outperform | — | ● Initiate | 2026-07-09 |
| Evercore ISI Group | Outperform | — | ↔ Maintain | 2026-04-30 |
| Morgan Stanley | Equal-Weight | — | ↔ Maintain | 2026-04-24 |
| Piper Sandler | Overweight | — | ↔ Maintain | 2026-04-21 |
| Citigroup | Buy | — | ● Initiate | 2026-04-15 |
| Barclays | Overweight | Equal-Weight → Overweight | ▲ Upgrade | 2026-03-17 |
| HSBC | Buy | Hold → Buy | ▲ Upgrade | 2026-02-09 |
| Stifel | Buy | — | ↔ Maintain | 2026-02-05 |
| UBS | Neutral | — | ↔ Maintain | 2026-02-05 |
| Wells Fargo | Overweight | — | ↔ Maintain | 2026-02-05 |
| Mizuho | Outperform | — | ↔ Maintain | 2026-01-20 |
BMO Capital
2026-07-09
Outperform
● Initiate
Evercore ISI Group
2026-04-30
Outperform
↔ Maintain
Morgan Stanley
2026-04-24
Equal-Weight
↔ Maintain
Piper Sandler
2026-04-21
Overweight
↔ Maintain
Citigroup
2026-04-15
Buy
● Initiate
Barclays
2026-03-17
Overweight
(from Equal-Weight)
▲ Upgrade
HSBC
2026-02-09
Buy
(from Hold)
▲ Upgrade
Stifel
2026-02-05
Buy
↔ Maintain
UBS
2026-02-05
Neutral
↔ Maintain
Wells Fargo
2026-02-05
Overweight
↔ Maintain
Mizuho
2026-01-20
Outperform
↔ Maintain
Profitability
Gross Margin
69.91%TTM
Op. Margin
15.47%TTM
ROE
10.82%TTM
Rev. Growth
6.20%YoY
Free Cash Flow
532.95MTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
2.80MRQ
Current Ratio
1.39MRQ
Cash
1.06BMRQ
Total Debt
116.04MMRQ
Net Debt
—MRQ
How ALGN Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 12.90B |
| Enterprise Value | 11.95B |
| Trailing P/E | 30.27 |
| Forward P/E | 14.55 |
| PEG Ratio (5yr) | 0.93 |
| Price/Sales (ttm) | 3.15 |
| Price/Book (mrq) | 3.11 |
| EV/Revenue | 2.92 |
| EV/EBITDA | 13.57 |
Share Statistics
| Avg Vol (3m) | 1.00M |
| Shares Outstanding | 71.62M |
| Float | 67.02M |
| % Held by Insiders | 6.82% |
| % Held by Institutions | 100.70% |
| Short Ratio | 4.52 |
| Short % of Float | 7.69% |
Profitability
| Gross Margin | 69.91% |
| Operating Margin (ttm) | 15.47% |
| Profit Margin | 10.50% |
| Return on Assets (ttm) | 7.23% |
| Return on Equity (ttm) | 10.82% |
Income Statement
| Revenue (ttm) | 4.10B |
| Revenue Growth (yoy) | 6.20% |
| Gross Profit (ttm) | 2.86B |
| EBITDA | 880.81M |
| Net Income (ttm) | 429.89M |
| Diluted EPS (ttm) | 5.95 |
| EPS Growth (yoy) | 23.90% |
Balance Sheet
| Total Cash (mrq) | 1.06B |
| Total Debt (mrq) | 116.04M |
| Debt / Equity (mrq) | 2.80 |
| Current Ratio (mrq) | 1.39 |
| Book Value / Share | 57.94 |
| Operating CF (ttm) | 691.59M |
| Free Cash Flow (ttm) | 532.95M |
Trading & Dividends
| Beta (5Y) | 1.67 |
| 50-Day MA | 172.72 |
| 200-Day MA | 166.03 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
Ownership Breakdown
Institutional 100.70%
Insider 6.82%
Short Interest
7.69% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in ALGN in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | LACOB JOSEPH S | Director | 1,745 | — | |
| 2026-05-20 | SIEGEL SUSAN E | Director | 1,745 | — | |
| 2026-05-20 | LARKIN CHARLES RAYMOND JR | Director | 2,326 | — | |
| 2026-05-20 | MORROW GEORGE J | Director | 1,745 | — | |
| 2026-05-20 | SAIA ANDREA LYNN | Director | 1,745 | — | |
| 2026-05-20 | CONROY KEVIN T | Director | 1,745 | — | |
| 2026-05-20 | DALLAS KEVIN J. | Director | 1,745 | — | |
| 2026-05-20 | POUL MOJDEH | Director | 1,745 | — | |
| 2026-05-20 | VITALONE BRITT J | Director | 1,443 | — | |
| 2026-05-20 | MYONG ANNE | Director | 1,745 | — | |
| 2026-02-20 | HOGAN JOSEPH M | Chief Executive Officer | 40,248 | — | |
| 2026-02-20 | COLETTI JULIE ANN | Officer | 5,864 | — | |
| 2026-02-20 | HOCKRIDGE STUART A | Officer | 4,310 | — | |
| 2026-02-20 | MORICI JOHN | Chief Financial Officer | 7,848 | — | |
| 2026-02-18 | MORICI JOHN | Chief Financial Officer | Sale at price 189.31 per share. | 7,969 | $1,508,646 |
| 2025-08-01 | HOGAN JOSEPH M | Chief Executive Officer | Purchase at price 131.49 per share. | 7,576 | $996,131 |
| 2025-05-21 | LACOB JOSEPH S | Director | 1,148 | — | |
| 2025-05-21 | SIEGEL SUSAN E | Director | 1,148 | — | |
| 2025-05-21 | LARKIN CHARLES RAYMOND JR | Director | Conversion of Exercise of derivative security at price 0.00 per share. | 1,531 | — |
| 2025-05-21 | MORROW GEORGE J | Director | Conversion of Exercise of derivative security at price 0.00 per share. | 1,148 | — |
| 2025-05-21 | SAIA ANDREA LYNN | Director | Conversion of Exercise of derivative security at price 0.00 per share. | 1,148 | — |
| 2025-05-21 | CONROY KEVIN T | Director | 1,148 | — | |
| 2025-05-21 | DALLAS KEVIN J. | Director | Conversion of Exercise of derivative security at price 0.00 per share. | 1,148 | — |
| 2025-05-21 | POUL MOJDEH | Director | Conversion of Exercise of derivative security at price 0.00 per share. | 1,148 | — |
| 2025-05-21 | MYONG ANNE | Director | 1,148 | — |
LACOB JOSEPH S
Director
2026-05-20
1,745 sh
—
SIEGEL SUSAN E
Director
2026-05-20
1,745 sh
—
LARKIN CHARLES RAYMOND JR
Director
2026-05-20
2,326 sh
—
MORROW GEORGE J
Director
2026-05-20
1,745 sh
—
SAIA ANDREA LYNN
Director
2026-05-20
1,745 sh
—
CONROY KEVIN T
Director
2026-05-20
1,745 sh
—
DALLAS KEVIN J.
Director
2026-05-20
1,745 sh
—
POUL MOJDEH
Director
2026-05-20
1,745 sh
—
VITALONE BRITT J
Director
2026-05-20
1,443 sh
—
MYONG ANNE
Director
2026-05-20
1,745 sh
—
HOGAN JOSEPH M
Chief Executive Officer
2026-02-20
40,248 sh
—
COLETTI JULIE ANN
Officer
2026-02-20
5,864 sh
—
HOCKRIDGE STUART A
Officer
2026-02-20
4,310 sh
—
MORICI JOHN
Chief Financial Officer
2026-02-20
7,848 sh
—
MORICI JOHN
Chief Financial Officer
Sale at price 189.31 per share.
2026-02-18
7,969 sh
$1,508,646
HOGAN JOSEPH M
Chief Executive Officer
Purchase at price 131.49 per share.
2025-08-01
7,576 sh
$996,131
LACOB JOSEPH S
Director
2025-05-21
1,148 sh
—
SIEGEL SUSAN E
Director
2025-05-21
1,148 sh
—
LARKIN CHARLES RAYMOND JR
Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21
1,531 sh
—
MORROW GEORGE J
Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21
1,148 sh
—
SAIA ANDREA LYNN
Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21
1,148 sh
—
CONROY KEVIN T
Director
2025-05-21
1,148 sh
—
DALLAS KEVIN J.
Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21
1,148 sh
—
POUL MOJDEH
Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21
1,148 sh
—
MYONG ANNE
Director
2025-05-21
1,148 sh
—